Birmingham, West Midlands -- (SBWIRE) -- 01/08/2014 -- Value Penny Stocks issues special report on Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Marvell Technology Group Ltd. (NASDAQ:MRVL), Generex Biotechnology Corporation (OTCMKTS:GNBT), Huntington Bancshares Incorporated (NASDAQ:HBAN).
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) ended its recent business day with the loss of -1.47% and closed at the price of $6.72 after opening at $6.94. The stock traded during its last trading session with the total volume of 14,651,734 shares, as compared to its average volume of 37.08 million shares. ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients. The company focuses on commercializing Iclusig (ponatinib), a cancer medicine; and developing additional molecularly targeted therapies to treat patients with blood cancers and solid tumors.
Has ARIA Found The Bottom and Ready To Move Up? Find Out Here
Marvell Technology Group Ltd. (NASDAQ:MRVL) remained among the day advancers and traded with volume of 12,632,460 shares in the last session, as compared to average volume of 6.17 million shares. In comparison with 52 week range of $7.73- $15.12, it faced lowest price of $14.65 during the last trading session whereas its day highest price was $15.12. The company’s total market capitalization is $7.23 billion, along with 491.90 million shares outstanding. Marvell Technology Group Ltd. designs, develops, and markets analog, mixed-signal, digital signal processing, and embedded and standalone ARM-based microprocessor integrated circuits. It offers mobile and wireless products comprising communications and applications processors; thin modems.
For How Long MRVL’s Gloss will Attract Investors? Find out via this report
Generex Biotechnology Corporation (OTCMKTS:GNBT) showed 11,759,170 shares in volume during the last trading session, while the average trading volume remained 2.32 million shares. The stock kicked off its trading session at $0.04 and closed at $0.0410 after mounting 7.33%. Generex Biotechnology Corporation, a development stage company, is engaged in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.
Will GNBT Continue To Move Higher? Find Out Here
Huntington Bancshares Incorporated (NASDAQ:HBAN) stock traded during its last trading session with the total traded volume of 11,770,309 shares versus its average volume of 8.05 million shares. The company opened its trade at the price of $9.62 and its closing price was $9.72 after gaining 1.46% for the day. Huntington Bancshares Incorporated operates as the holding company for The Huntington National Bank that provides commercial, small business, and consumer banking services. The company’s Retail and Business Banking segment offers various financial products and services, including checking, savings, and money market accounts.
Why Should Investors Buy HBAN After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)